   |
|   |

| |
|
The Scientific Advisory Board (SAB) was created in 2002 to provide ongoing, high-level scientific advice to IPM. IPM’s scientific agenda is based on a set of decision-making criteria approved by the SAB in 2003. Due to its size, the full SAB does not meet regularly. IPM staff consults as needed with individual SAB members who have expertise in particular areas of microbicide research and/or drug development. IPM provides SAB members with updates on its work, including a comprehensive annual report on its science program.
 |
| Scientific Advisory Board Members |
 |
 |
, Chair, Professor in Molecular Infection
St. George's Hospital Medical School University of London, UK |
| |
|
 |
, Professor
Department of Obstetrics and Gynaecology, College of Health Sciences, University of Zimbabwe |
| |
|
 |
, Director
Product Development, CONRAD, USA |
| |
|
 |
, Principal Investigator, MTN, Co-Principal Investigator
Magee-Womens Hospital University of Pittsburgh School of Medicine, USA |
| |
|
 |
, Director
Clinical Development-Reproductive Health, Population Council, USA |
| |
|
 |
, Medical Director
ReProtect, Inc., USA |
| |
|
 |
School of Public Health, Makerere University Kampala, Uganda |
|
 |
 |
, Senior Director
Nonclinical Safety Products, GlaxoSmithKline, UK |
| |
|
 |
, Chief
Sexual Transmission and Injection Drug Use Studies Section,
Centers for Disease Control, USA |
| |
|
 |
, Professor of Virology
University College London Medical School, UK |
| |
|
 |
, Epidemiologist, Bill & Melinda Gates Foundation |
| |
|
 |
, Director of Biostatistics
Family Health International, USA |
| |
|
 |
, Director
Global Clinical Development,
Tibotec BVBA, Belgium |
| |
|
 |
, Professor
Desmond Tutu Hiv-Research Centre, Faculty of Health Sciences/Medical School, South Africa |
| |
|
| |
|
|
 |
|
|
| |
IPM Headquarters: 8401 Colesville Road • Suite 200 • Silver Spring, MD 20910
(p) +1 301-608-2221 • (f) +1 301-608-2241
© Copyright, International Partnership for Microbicides |
|
|   |